CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zantek, N. D.
Right arrow Articles by Kinch, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zantek, N. D.
Right arrow Articles by Kinch, M. S.
Cell Growth & Differentiation Vol. 10, 629-638, September 1999
© 1999 American Association for Cancer Research

E-Cadherin Regulates the Function of the EphA2 Receptor Tyrosine Kinase1

Nicole Dodge Zantek, Minoudokht Azimi, Mary Fedor-Chaiken, Bingcheng Wang, Robert Brackenbury and Michael S. Kinch2

Department of Basic Medical Sciences and Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907 [N. D. Z., M. A., M. S. K.]; Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, Cincinnati, Ohio 45267 [M-F. C.]; and Department of Medicine, Rammelkamp Center for Research, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio 44109 [B. W.]

EphA2 is a member of the Eph family of receptor tyrosine kinases, which are increasingly understood to play critical roles in disease and development. We report here the regulation of EphA2 by E-cadherin. In nonneoplastic epithelia, EphA2 was tyrosine-phosphorylated and localized to sites of cell-cell contact. These properties required the proper expression and functioning of E-cadherin. In breast cancer cells that lack E-cadherin, the phosphotyrosine content of EphA2 was decreased, and EphA2 was redistributed into membrane ruffles. Expression of E-cadherin in metastatic cells restored a more normal pattern of EphA2 phosphorylation and localization. Activation of EphA2, either by E-cadherin expression or antibody-mediated aggregation, decreased cell-extracellular matrix adhesion and cell growth. Altogether, this demonstrates that EphA2 function is dependent on E-cadherin and suggests that loss of E-cadherin function may alter neoplastic cell growth and adhesion via effects on EphA2.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
B. E. Perez White, R. Ventrella, N. Kaplan, C. J. Cable, P. M. Thomas, and S. Getsios
EphA2 proteomics in human keratinocytes reveals a novel association with afadin and epidermal tight junctions
J. Cell Sci., January 1, 2017; 130(1): 111 - 118.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. Locard-Paulet, L. Lim, G. Veluscek, K. McMahon, J. Sinclair, A. van Weverwijk, J. D. Worboys, Y. Yuan, C. M. Isacke, and C. Jorgensen
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration
Sci. Signal., February 9, 2016; 9(414): ra15 - ra15.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Cheng, M. M. Ansari, J. A. Cooper, and X. Gong
EphA2 and Src regulate equatorial cell morphogenesis during lens development
Development, October 15, 2013; 140(20): 4237 - 4245.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
N. Sugiyama, E. Gucciardo, O. Tatti, M. Varjosalo, M. Hyytiainen, M. Gstaiger, and K. Lehti
EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion
J. Cell Biol., April 29, 2013; 201(3): 467 - 484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rao, J. L. Taylor, N. Chi-Sabins, M. Kawabe, W. E. Gooding, and W. J. Storkus
Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Cancer Res., July 1, 2012; 72(13): 3196 - 3206.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
B. Foveau, G. Boulay, S. Pinte, C. Van Rechem, B. R. Rood, and D. Leprince
The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1)
J. Biol. Chem., February 17, 2012; 287(8): 5366 - 5378.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Y. Wakayama, K. Miura, H. Sabe, and N. Mochizuki
EphrinA1-EphA2 Signal Induces Compaction and Polarization of Madin-Darby Canine Kidney Cells by Inactivating Ezrin through Negative Regulation of RhoA
J. Biol. Chem., December 23, 2011; 286(51): 44243 - 44253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. K. Wendt, M. A. Taylor, B. J. Schiemann, and W. P. Schiemann
Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
Mol. Biol. Cell, July 15, 2011; 22(14): 2423 - 2435.
[Abstract] [Full Text] [PDF]


Home page
Cancer Genomics ProteomicsHome page
B. P. Fox and R. P. Kandpal
A Paradigm Shift in EPH Receptor Interaction: Biological Relevance of EPHB6 Interaction with EPHA2 and EPHB2 in Breast Carcinoma Cell Lines
Cancer Genomics Proteomics, July 1, 2011; 8(4): 185 - 193.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Lin, K. Gordon, N. Kaplan, and S. Getsios
Ligand Targeting of EphA2 Enhances Keratinocyte Adhesion and Differentiation via Desmoglein 1
Mol. Biol. Cell, November 15, 2010; 21(22): 3902 - 3914.
[Abstract] [Full Text] [PDF]


Home page
Biochem. J.Home page
N. K. Noren, N.-Y. Yang, M. Silldorff, R. Mutyala, and E. B. Pasquale
Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor
Biochem. J., September 15, 2009; 422(3): 433 - 442.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kawabe, M. Mandic, J. L. Taylor, C. A. Vasquez, A. K. Wesa, L. M. Neckers, and W. J. Storkus
Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells
Cancer Res., September 1, 2009; 69(17): 6995 - 7003.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. Annamalai, X. Liu, U. Gopal, and J. S. Isaacs
Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis
Mol. Cancer Res., July 1, 2009; 7(7): 1021 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Brannan, W. Dong, L. Prudkin, C. Behrens, R. Lotan, B. N. Bekele, I. Wistuba, and F. M. Johnson
Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2009; 15(13): 4423 - 4430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. Miura, J.-M. Nam, C. Kojima, N. Mochizuki, and H. Sabe
EphA2 Engages Git1 to Suppress Arf6 Activity Modulating Epithelial Cell-Cell Contacts
Mol. Biol. Cell, April 1, 2009; 20(7): 1949 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Wykosky and W. Debinski
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Mol. Cancer Res., December 1, 2008; 6(12): 1795 - 1806.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Wesa, C. J. Herrem, M. Mandic, J. L. Taylor, C. Vasquez, M. Kawabe, T. Tatsumi, M. S. Leibowitz, J. H. Finke, R. M. Bukowski, et al.
Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists
J. Immunol., December 1, 2008; 181(11): 7721 - 7727.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Cooper, A. I. Son, D. Komlos, Y. Sun, N. J. Kleiman, and R. Zhou
Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract
PNAS, October 28, 2008; 105(43): 16620 - 16625.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. Lackmann and A. W. Boyd
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?
Sci. Signal., April 15, 2008; 1(15): re2 - re2.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. Arvanitis and A. Davy
Eph/ephrin signaling: networks
Genes & Dev., February 15, 2008; 22(4): 416 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W. B. Fang, R. C. Ireton, G. Zhuang, T. Takahashi, A. Reynolds, and J. Chen
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
J. Cell Sci., February 1, 2008; 121(3): 358 - 368.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski
Interleukin-13 Receptor {alpha}2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
Clin. Cancer Res., January 1, 2008; 14(1): 199 - 208.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Wykosky, D. M. Gibo, and W. Debinski
A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells
Mol. Cancer Ther., December 1, 2007; 6(12): 3208 - 3218.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R Holm, S Knopp, Z Suo, C Trope, and J M Nesland
Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis
J. Clin. Pathol., October 1, 2007; 60(10): 1086 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Hammond, R. Lutterbuese, S. Roff, P. Lutterbuese, B. Schlereth, E. Bruckheimer, M. S. Kinch, S. Coats, P. A. Baeuerle, P. Kufer, et al.
Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct
Cancer Res., April 15, 2007; 67(8): 3927 - 3935.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-G. Kang, J. M. Jenabi, J. Zhang, N. Keshelava, H. Shimada, W. A. May, T. Ng, C. P. Reynolds, T. J. Triche, and P. H.B. Sorensen
E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase
Cancer Res., April 1, 2007; 67(7): 3094 - 3105.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. B. Larsen, M. W. Pedersen, M.-T. Stockhausen, M. V. Grandal, B. v. Deurs, and H. S. Poulsen
Activation of the EGFR Gene Target EphA2 Inhibits Epidermal Growth Factor-Induced Cancer Cell Motility
Mol. Cancer Res., March 1, 2007; 5(3): 283 - 293.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Abraham, D. W. Knapp, L. Cheng, P. W. Snyder, S. K. Mittal, D. S. Bangari, M. Kinch, L. Wu, J. Dhariwal, and S. I. Mohammed
Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder
Clin. Cancer Res., January 15, 2006; 12(2): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Tanaka, R. Kamata, and R. Sakai
EphA2 Phosphorylates the Cytoplasmic Tail of Claudin-4 and Mediates Paracellular Permeability
J. Biol. Chem., December 23, 2005; 280(51): 42375 - 42382.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Andersen, J. Mejlvang, S. Mahmood, I. Gromova, P. Gromov, E. Lukanidin, M. Kriajevska, J. K. Mellon, and E. Tulchinsky
Immediate and Delayed Effects of E-Cadherin Inhibition on Gene Regulation and Cell Motility in Human Epidermoid Carcinoma Cells
Mol. Cell. Biol., October 15, 2005; 25(20): 9138 - 9150.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Mol. Cancer Res., October 1, 2005; 3(10): 541 - 551.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
A. P. Putzke, S. T. Hikita, D. O. Clegg, and J. H. Rothman
Essential kinase-independent role of a Fer-like non-receptor tyrosine kinase in Caenorhabditis elegans morphogenesis
Development, July 15, 2005; 132(14): 3185 - 3195.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. I. Ivanov, A. A. Steiner, A. C. Scheck, and A. A. Romanovsky
Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats
Physiol Genomics, April 1, 2005; 21(2): 152 - 160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Xu, W. Tian, J. N. Lindsley, T. T. Oyama, J. M. Capasso, C. J. Rivard, H. T. Cohen, S. M. Bagnasco, S. Anderson, and D. M. Cohen
EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo
Am J Physiol Renal Physiol, March 7, 2005; 288(4): F855 - F866.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. Miao, K. Strebhardt, E. B. Pasquale, T.-L. Shen, J.-L. Guan, and B. Wang
Inhibition of Integrin-mediated Cell Adhesion but Not Directional Cell Migration Requires Catalytic Activity of EphB3 Receptor Tyrosine Kinase: ROLE OF RHO FAMILY SMALL GTPases
J. Biol. Chem., January 14, 2005; 280(2): 923 - 932.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. J. Herrem, T. Tatsumi, K. S. Olson, K. Shirai, J. H. Finke, R. M. Bukowski, M. Zhou, A. L. Richmond, I. Derweesh, M. S. Kinch, et al.
Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma
Clin. Cancer Res., January 1, 2005; 11(1): 226 - 231.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Hu, K. L. Carles-Kinch, D. P. Zelinski, and M. S. Kinch
EphA2 Induction of Fibronectin Creates a Permissive Microenvironment for Malignant Cells
Mol. Cancer Res., October 1, 2004; 2(10): 533 - 540.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. H. Thaker, M. Deavers, J. Celestino, A. Thornton, M. S. Fletcher, C. N. Landen, M. S. Kinch, P. A. Kiener, and A. K. Sood
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Clin. Cancer Res., August 1, 2004; 10(15): 5145 - 5150.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
X. Qian, T. Karpova, A. M. Sheppard, J. McNally, and D. R. Lowy
E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases
EMBO J., April 21, 2004; 23(8): 1739 - 1784.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
M. Tanaka, R. Ohashi, R. Nakamura, K. Shinmura, T. Kamo, R. Sakai, and H. Sugimura
Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2
EMBO J., March 10, 2004; 23(5): 1075 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Dobrzanski, K. Hunter, S. Jones-Bolin, H. Chang, C. Robinson, S. Pritchard, H. Zhao, and B. Ruggeri
Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist
Cancer Res., February 1, 2004; 64(3): 910 - 919.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. de Saint-Vis, C. Bouchet, G. Gautier, J. Valladeau, C. Caux, and P. Garrone
Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin
Blood, December 15, 2003; 102(13): 4431 - 4440.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. L. Pratt and M. S. Kinch
Ligand Binding Up-Regulates EphA2 Messenger RNA Through the Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Pathway
Mol. Cancer Res., December 1, 2003; 1(14): 1070 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. T. Coffman, M. Hu, K. Carles-Kinch, D. Tice, N. Donacki, K. Munyon, G. Kifle, R. Woods, S. Langermann, P. A. Kiener, et al.
Differential EphA2 Epitope Display on Normal versus Malignant Cells
Cancer Res., November 15, 2003; 63(22): 7907 - 7912.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Lu, K. D. Miller, Y. Gokmen-Polar, M.-H. Jeng, and M. S. Kinch
EphA2 Overexpression Decreases Estrogen Dependence and Tamoxifen Sensitivity
Cancer Res., June 15, 2003; 63(12): 3425 - 3429.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Palmer and R. Klein
Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function
Genes & Dev., June 15, 2003; 17(12): 1429 - 1450.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Kinch, M.-B. Moore, and D. H. Harpole Jr.
Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival
Clin. Cancer Res., February 1, 2003; 9(2): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Koolpe, M. Dail, and E. B. Pasquale
An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor
J. Biol. Chem., December 6, 2002; 277(49): 46974 - 46979.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Walker-Daniels, D. J. Riese II, and M. S. Kinch
c-Cbl-Dependent EphA2 Protein Degradation Is Induced by Ligand Binding
Mol. Cancer Res., November 1, 2002; 1(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. D. Kikawa, D. R. Vidale, R. L. Van Etten, and M. S. Kinch
Regulation of the EphA2 Kinase by the Low Molecular Weight Tyrosine Phosphatase Induces Transformation
J. Biol. Chem., October 18, 2002; 277(42): 39274 - 39279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Carles-Kinch, K. E. Kilpatrick, J. C. Stewart, and M. S. Kinch
Antibody Targeting of the EphA2 Tyrosine Kinase Inhibits Malignant Cell Behavior
Cancer Res., May 1, 2002; 62(10): 2840 - 2847.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G. Williams, E.-J. Williams, and P. Doherty
Dimeric Versions of Two Short N-cadherin Binding Motifs (HAVDI and INPISG) Function as N-cadherin Agonists
J. Biol. Chem., February 8, 2002; 277(6): 4361 - 4367.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Munarini, R. Jager, S. Abderhalden, G. Zuercher, V. Rohrbach, S. Loercher, B. Pfanner-Meyer, A.-C. Andres, and A. Ziemiecki
Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase
J. Cell Sci., January 1, 2002; 115(1): 25 - 37.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
A. W. Boyd and M. Lackmann
Signals from Eph and Ephrin Proteins: A Developmental Tool Kit
Sci. Signal., December 11, 2001; 2001(112): re20 - re20.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. D. Zantek, J. Walker-Daniels, J. Stewart, R. K. Hansen, D. Robinson, H. Miao, B. Wang, H.-J. Kung, M. J. Bissell, and M. S. Kinch
MCF-10A-NeoST: A New Cell System for Studying Cell-ECM and Cell-Cell Interactions in Breast Cancer
Clin. Cancer Res., November 1, 2001; 7(11): 3640 - 3648.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. R. Hess, E. A. Seftor, L. M. G. Gardner, K. Carles-Kinch, G. B. Schneider, R. E. B. Seftor, M. S. Kinch, and M. J. C. Hendrix
Molecular Regulation of Tumor Cell Vasculogenic Mimicry by Tyrosine Phosphorylation: Role of Epithelial Cell Kinase (Eck/EphA2)
Cancer Res., April 1, 2001; 61(8): 3250 - 3255.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
D. P. Zelinski, N. D. Zantek, J. C. Stewart, A. R. Irizarry, and M. S. Kinch
EphA2 Overexpression Causes Tumorigenesis of Mammary Epithelial Cells
Cancer Res., March 1, 2001; 61(5): 2301 - 2306.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C. Y. Sasaki, H. Lin, P. J. Morin, and D. L. Longo
Truncation of the Extracellular Region Abrogrates Cell Contact but Retains the Growth-suppressive Activity of E-cadherin
Cancer Res., December 1, 2000; 60(24): 7057 - 7065.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
S. Orsulic and R. Kemler
Expression of Eph receptors and ephrins is differentially regulated by E-cadherin
J. Cell Sci., May 15, 2000; 113(10): 1793 - 1802.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1999 by the American Association of Cancer Research.